Studies of early schizophrenia offer several advantages for efforts to unravel the biology, treatment, and outcome of this disorder. A review of available first-episode studies, however, suggests marked variability in findings, frequently attributed to the presumed heterogeneity of the disorder. Another cause may be variation in definitions and criteria used. Thus, attention has turned to the study of patients experiencing their first episode of psychosis. Although this strategy will not control for the true underlying heterogeneity of the illness, it provides a valuable method for homogenizing variability due to course. For this strategy to be effective, definition and operationalization of criteria for such studies are crucial. In this article, we reviewed assessment methods used in firstepisode studies in the recent literature and found marked inconsistencies. We offer a framework for definition of patient populations for studies of early schizophrenia and outline some key variables that may serve as the basis for fuller characterization of the disorder. It is important to provide data on such variables to enhance comparability among studies of early schizophrenia and to facilitate meaningful interpretation of data.
Thus, attention has turned to the study of patients experiencing their first episode of psychosis. Although this strategy will not control for the true underlying heterogeneity of the illness, it provides a valuable method for homogenizing variability due to course. For this strategy to be effective, definition and operationalization of criteria for such studies are crucial. In this article, we reviewed assessment methods used in firstepisode studies in the recent literature and found marked inconsistencies. We offer a framework for definition of patient populations for studies of early schizophrenia and outline some key variables that may serve as the basis for fuller characterization of the disorder. It is important to provide data on such variables to enhance comparability among studies of early schizophrenia and to facilitate meaningful interpretation of data.
First-Episode Strategy
A frequently noted problem in schizophrenia research is the wide variability of findings in the literature. This variability is commonly attributed to the presumed heterogeneity of the schizophrenic syndrome, but an equally important cause may be the widely discrepant definitions and criteria used for the populations in the studies, making comparability of studies quite difficult. Use of patients with varying degrees of chronicity and at varying stages of treatment makes generalization of any findings unwise.
Study of "first-episode," "firstadmission," or "early" schizophrenia is an important approach to these problems. This strategy has several advantages: (1) the confounding effects of chronicity and institutionalization on the parameters being studied can be minimized; (2) the possibility of obtaining drug-naive subjects, particularly valuable for biological research, is unique to this population; (3) initiation of research at this stage offers the opportunity to carry out prospective longitudinal studies of biology, course, and outcome; (4) the likelihood of detecting biological or psychological factors that are etiologically or pathophysiologically significant may be higher at illness onset; and (5) studies of firstepisode patients can increase understanding of the substantial variability in clinical morbidity seen in the first few years after schizophrenia onset. After about 5 years, the outcome in schizophrenia is less likely to manifest major fluctuations in severity (Shepherd et al. 1989; Eaton et al. 1992 ). This may be related to the possibility that the schizophrenic syndrome seems more heterogeneous early in the course and the diagnosis may be revised in many patients.
There are two major difficulties in conducting research with patients early in the course of the illness. First, the number of incident cases in any given center is comparatively small, so amassing a sample of rea-
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SCHIZOPHRENIA BULLETIN sonable size may take far longer than accruing a sample of mixed chronicity. Second, diagnosis of patients experiencing a first episode is difficult and almost certainly requires subsequent rediagnosis for many patients, some of whom will receive other diagnoses.
Therefore, despite the unique opportunities discussed above, the number of studies examining firstepisode schizophrenia has been relatively small in comparison to the magnitude of the literature on schizophrenia in general. Further, even studies that focus on the first-episode population have frequently reported conflicting findings, possibly because of widely varying definitions of the population or, as will be discussed below, because of small sample sizes.
Variability in Findings in FirstEpisode Studies. Biological psychiatric research in schizophrenia is replete with instances of variability in findings and failures of replication. An example in the recent neurobiological literature in schizophrenia involves the observation of increased D 2 (dopamine) receptor density in positron emission tomography (PET) scan studies of first-episode schizophrenic patients (Wong et al. 1986 ). Other groups (e.g., Farde et al. 1990) have been unable to replicate this finding. Examination of the clinical characteristics of the patient populations in these studies reveals differences. The Farde sample (n = 18) were younger patients (mean age 24.2 years) with briefer illness (10 ± 3.7 months) compared to the Wong series (n = 10; age = 31.2 ± 3.6 years; duration of illness = 5 ± 8 years). Further, in the Wong group control subjects were younger than the patients by about 7 years; the Farde control group was older than the patients. Regional blood flow studies using PET scans have shown increased glucose consumption (Cleghorn et al. 1988) and unchanged blood flow (Sheppard et al. 1983) in frontal lobes of first-episode schizophrenic patients. Similarly, there is considerable variability in the neuromorphological characteristics in firstepisode schizophrenic patients reported by different groups with normal (Owens et al. 1985) and abnormal (Weinberger et al. 1982; DeLisi et al. 1991) findings. Although differences in the findings could result from variations in imaging methodology, it is also possible that they are a function of differences in clinical populations.
Variability in Definitions-Review of First-Episode Studies. We propose in this article that the noted biological and clinical variability in early schizophrenia derives at least in part from the use of different definitions of first-episode schizophrenia, as an example of criterion variance. To examine this issue, we reviewed recent studies of first-episode psychoses to examine variability in the definitions and clinical characterization of the populations studied. We included articles that describe samples of firstepisode, early, recent-onset, or drugnaive schizophrenic patients. We excluded retrospective chart reviews and case register studies because in such studies the investigator has no control of the data quality. We sought to answer the following questions: (1) How have investigators operationally defined first episode? (2) Are the definitions comparable across studies? (3) Have clinical data been presented in these reports that could allow alternative definitions or criteria to be applied?
To examine criteria and terminology used to define early schizophrenia, we abstracted the following data: onset definition (age of onset of first psychotic symptoms, first prodromal symptoms, first hospitalization, and first mental health contact); onset type (acute or gradual); use of structured diagnostic interviews; assessment setting (inpatient and outpatient); use of exclusion criteria; past treatment; and severity measures. For the purposes of this analysis, we considered multiple publications based on a single patient cohort as a single unit. On the other hand, if the same research group reported findings on separate cohorts of patients, we listed them separately. Computer search using the key words "first episode" or "first admission" yielded less than onethird of the studies; therefore, we searched the major journals manually for an 11-year period (1981-1992) . Reports reflecting new patient cohorts in the Schizophrenia Bulletin 1992 theme issues on this topic were included as well. Table 1 identifies the 53 studies that met our criteria, their patient populations, and aims. Table 2 provides a description of other critical variables including diagnostic criteria, onset, and psychosis severity. Table 3 summarizes our  observations. Most of the studies are small in scale-only 13 had more than 50 patients. Many studies included a combination of first-episode and multiple-episode patients. In the majority of these studies, descriptive data were not provided separately for first-and multiple-episode patients. Nearly two-thirds were biological studies, mostly focusing on brain imaging.
All studies reported use of formal diagnostic criteria such as Research Diagnostic Criteria (RDC; Spitzer et al. 1978b) (57) 44 (83) 23 (43) 9 (17) 28 (53) 16 (30) 12 (23) 19 (36) 21 (40) 9 (17) 20 ( Explicit exclusion criteria were not reported in the majority of studies. The inclusion and exclusion criteria are also variable. The issues of comorbidity, organic antecedent illness, and substance abuse have not been addressed in many studies.
There is, therefore, substantial lack of consistency in the definition and characterization of patients in the studies of first-episode psychosis in the literature. Such inconsistency may result in difficulties comparing findings among studies. We attempt here to propose some clearer definitions and suggest key variables on which data need to be collected and provided in the literature to permit cross-study comparison and meaningful interpretation of data.
Definitions of Course
It is important to define variables that characterize course in firstepisode schizophrenia studies. We provide a conceptual scheme (see figure 1 ) and some working definitions for key time points in studies of early or first-episode schizophrenia. These are offered as tentative hypotheses, to be tested and revised as more empirical data emerge. The proposed scheme focuses on observable phenomena to encompass patients with varying courses of early illness. For this purpose, we have followed principles similar to those applied by Frank and colleagues (1991) for definitions of terms in major depressive disorder.
Early Versus First-Episode Psychosis. The terms "early" and "recent onset" schizophrenia must be distinguished from "first episode," "first onset," and "first admission" because (1) the first term may or may not encompass each of the other two, and all three have different connotations, depending on the definition of onset; (2) first episode may continue for several years on occasion; and (3) first admission may not necessarily be for the first episode. The use of the "early epoch" as a critical phase in the course of schizophrenia could serve as a unifying concept for this purpose (Carpenter and Kirkpatrick 1988). Further, the term first episode indicates the state (episode vs. interepisodic); the term early denotes the stage or "epoch" illness; and first admission denotes the time of intervention. Variable use of such terms in the literature could lead to variability in study populations.
Episode. An episode is a period, with a specified minimum duration, during which the patient manifests a specified minimum number of symptoms to fulfill syndromal criteria for a given category of psychotic disorder (e.g., schizophrenia, delusional Relapse of Episode disorder). We suggest that the definition of an episode should be confined to syndromes, such as psychoses, that tend to vary over time. "Onset of episode" is defined by the date of the beginning of the specific symptoms that define the syndrome. "End of episode" is defined by a remission of the symptoms for a specified minimum length of time. "Remission" can be partial, including the persistence of some residual symptoms, or full, when the subject has no more than minimal symptoms.
The specific syndromal criteria used foi the definition of an episode may be derived from any of the criterion-based diagnostic systems such as RDC and DSM-III-R. Periodic ratings of target symptoms using well-established instruments such as the Brief Psychiatric Rating Scale (BPRS; Overall and Gorham 1962) and the Scale for Assessment of Negative Symptoms (SANS; Andreasen 1984) are useful to quantify the severity of the episode (Falloon et al. 1983) and to develop criteria for defining both onset and end. For example, onset of an episode could be defined by a score of at least "moderate" on two psychotic symptoms on the BPRS and the end of the episode defined by a rating of no more than "mild" on the same target symptom.
Illness. Illness is defined by the period encompassing all symptoms unique to the clinical description of the disorder, including both episodic (e.g., psychotic) and relatively enduring (e.g., prodromal and residual) symptoms. Illness onset is defined by the date of beginning of continuous symptoms or signs that go on for a specified minimum duration. The terms "prodromal" and "residual" are defined in temporal relation to the first psychotic episode.
Key Variables for Characterization
Definitions of key descriptive characteristics in first-episode studies will (1) enhance comparability of data across studies; (2) help specify to which populations the findings can be meaningfully generalized; (3) facilitate multicenter studies that could enhance statistical power in research into this relatively rare and difficult-to-study population; and (4) allow later rediagnosis and recategorization.
The precise inclusion and exclusion criteria to be used in any study depend on the primary hypotheses in the study; often the attempt will be to focus on a specific variable and to minimize confounding effects of other variables. For this reason, it is unwise to state a priori that certain inclusion and exclusion criteria should be used uniformly in studies of early schizophrenia. The most useful approach is to retain flexibility in regard to the criteria and to ensure that data on certain key clinical and sociodemographic variables be collected and provided in the literature. Table 4 lists the significant variables. They include characterization of onset, diagnostic characterization, illness severity and symptom profile, assessment setting, and treatment history.
Characterization of Onset. A key variable in the definition of first episode is onset. There is extensive evidence for differences in symptomatology (Pearlson et al. 1989) , paranoid competence (Burack and Zigler 1989), neurodevelopmental anomalies (Foster-Green et al. 1987) , family history (Shimizu et al. 1988) , cognitive and occupational function (Johnstone et al. 1989) , and treatment response (Pearlson et al. 1989) between early and later onset schizophrenia. The age of onset of symptoms and treatment are key variables needed to interpret research in early schizophrenia.
In addition, varying definitions may generate varying diagnostic labels, especially in duration-based diagnostic criteria systems. Consider the following examples: (1) A patient has a 1-year history of aloofness, a 2-week history of hallucinations, and history of a depressive episode 5 years ago. Using the criteria of Feighner (Feighner et al. 1972) he would be diagnosed as having an unspecified psychiatric disorder if onset is defined by "any psychiatric symptoms," but as having schizophrenia if the onset is based on "prodromal symptoms." (2) A patient stopped working 2 years ago; he manifested vague odd beliefs for 4 months and bizarre delusions for 2 weeks. Using DSM-III-R criteria, he would be diagnosed as having schizophrenia if we used decline in functioning to define onset, but as having schizophreniform disorder if prodromal or psychotic symptoms were used to define onset. Thus, using different onset definitions, one derives different diagnostic conclusions, even given the same clinical picture and the same criterion system.
Date of Onset. How to date onset reliably has been a vexing problem, because inevitably the date must be based on retrospective data, which carries an inherent risk of biased or distorted recall. The more remote in time, the less accurate the history is likely to be. Further, the illness state may affect accuracy of recall. For these reasons, onset information should be collected when patients are symptomatically stable. Corroborative information from family members and other informants is essential.
Defining onset by measures such as hospital admission or first psychotic symptoms enjoys the advantage of more reliability, but little is known about the validity of such definitions, as opposed to other less reliable measures of onset like first prodromal symptoms or decline in functioning. The optimal way to compare the validity of the diverse definitions is to collect data on each measure as well as other potentially validating data such as course, biology, family history, and treatment response.
Definitions of Onset. Defining onset involves many difficulties. First, it is often unclear whether the onset should be dated from the presentation of the first symptom or from the date that criteria for full syndrome were first met. Second, the distinction between a prodrome and a psychotic episode is also unclear, and some form of severity criterion needs to be used. For example, Subotnik and Nuechterlein (1988) used a rating of 6 or 7 on selected BPRS items to define psychotic relapse. Third, what constitutes the prodrome is controversial (Keith and Matthews 1991). Two types of prodromal symptoms have been described: a "gradually emerging psychosis" and an "early pattern of negative symptoms" (Carpenter and Kirkpatrick 1988). The former can be reliably rated (Herz and Melville 1980) and may be shorter in duration (1-2 months), while the latter may be more difficult to date for the purpose of onset and may be longer in duration (Keith and Matthews 1991). However, these studies of prodromal symptoms have generally been conducted in relapsing patients with established diagnoses. There are few systematic studies of the nature of the prodrome at the onset of schizophrenia. Thus, data on the onset of both early psychotic symptoms and negative symptoms should be collected.
With these caveats in mind, onset of the following significant clinical events should be dated as closely as possible:
1. Decline in social functioning regardless of relationship to psychopathology.
2. First onset of any psychiatric symptoms.
3. First onset of early psychotic symptoms.
4. First onset of negative symptoms.
5. First treatment, which could influence the course and duration of the first episode and possibly the assigned diagnoses.
6. First hospital admission.
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Age of onset for these indicators of the course of illness should be recorded as well.
Mode of Onset. In addition to date of onset, the mode of onset (i.e., sudden vs. gradual) may be important in understanding course (Carpenter and Kirkpatrick 1988; McGlashan 1988). Defining sudden and gradual may be problematic. Alternatively, rapidity of onset for key onset characteristics (psychotic symptoms, both classes of prodromal symptoms, and decline in social functioning) should be rated. Precise dating may not be possible; time span dating such as the following may be used: less than 1 week, 1 week to 1 month, 1 to 6 months, 6 months to a year, more than 1 year.
Diagnosis
Criteria. As can be seen from Assessment Setting.' Both socioeconomic and clinical factors influence treatment seeking; some schizophrenic patients are either untreated or are treated as outpatients. There may be differences in these populations, making it difficult to generalize the findings from one to the other. Further, inpatients tend to have more severe illness than outpatients. Thus, it is important to provide data on whether the index evaluation was in an outpatient or inpatient setting or an alternative setting such as a partial or day hospital.
Western Psychiatric Institute and Clinic (WPIC) Study of First-Episode Psychosis
Our ongoing study of first-episode psychosis is designed to address many of the methodological issues raised in this article. First, we include a broad group of psychotic patients, selected on the basis of symptom presentation rather than diagnosis. Thus, subsequent diagnosis becomes a variable for study. Initial diagnosis is derived from both structured clinical interviews using the Structured Clinical Interview for DSM-III-R (SCID; Spitzer et al. 1987 ) and a Diagnostic and Disposition Conference conducted 3 to 4 weeks after study entry. At this conference all clinical information, including treatment response and research assessments, is reviewed by the clinical and research team and a consensus diagnosis and dissenting diagnoses are recorded. Diagnostic re-review is conducted for all subjects at subsequent scheduled assessment points of 1, 2, and 4 years, unless the initial diagnosis is uncertain or hinges on short-term outcome (e.g., schizophreniform disorder). In such cases, rediagnosis, including the SCID, is completed at 6 months.
Because a major focus of the studies conducted with our patients is biological, we exclude patients who have had past treatment with antipsychotic medication or lithium, although we do not exclude those who have received other classes of psychotropic drugs. In general, patients are admitted to an inpatient unit at the WPIC, although occasionally patients may be clinically managed as outpatients. In addition to diagnostic assessment, an array of standardized rating scales is also completed at study recruitment and at all followup points. Detailed information is collected regarding onset of illness, including the range of characteristics identified in table 4. We also gather information regarding rapidity of onset, as described above, for as many of the variables as possible, always for first hospitalization and first psychotic symptoms. As we have noted in our review, the reli-508 SCHIZOPHRENIA BULLETIN ability of some of these variables may be questionable; for some patients they are difficult to distinguish (e.g., the first psychotic symptoms may be the first psychiatric symptoms).
Patients are excluded if psychotic symptoms immediately follow a head injury or if magnetic resonance imaging (MRI) reveals focal lesions. A history of head injury-even if it was associated with loss of consciousness-does not exclude subjects unless psychotic symptoms are documented at the time. Comorbidity for DSM-III-R major Axis I disorders, including psychoactive substance dependence, excludes patients, but current drug and alcohol abuse in the absence of dependence does not. Patients are not excluded based on a history of birth trauma, although detailed birth, perinatal, and developmental histories are gathered. Data regarding neurological soft signs (Buchanan and Heinrichs 1989) are gathered at initial contact and at followup. History of treatment with psychopharmacologic medications is also collected.
Our study is prospective. We rely on longitudinal reassessment of patients to develop one of the major comparison groups for the schizophrenic patients, namely subjects with positive psychotic symptoms who do not meet diagnostic criteria for schizophrenia. We anticipate that group membership may change over time because of changes in the criteria and because of changes in patients as their illnesses evolve and resolve.
Maximizing the Value of the First-Episode Strategy
Despite the difficulties inherent in studying incident cases of schizophrenia or psychosis, there is an active and lively literature in this field, as our review of more than 50 studies and two issues of the Schizophrenia Bulletin (Vol. 18, No. 2, 1992; Vol. 18, No. 3, 1992) attest. The study of incident cases has the potential to provide valuable insights into various aspects of schizophrenia. The following measures will increase the research yield by facilitating the collection of comparable data at multiple research centers.
• Diagnosis should involve the use of accepted diagnostic criteria and standardized research diagnostic interviews; of consensus diagnosis based on multiple sources of information and both cross-sectional and longitudinal information; of appropriate exclusion criteria, both to delimit psychotic from nonpsychotic and organic disorders and to distinguish among psychotic disorders; and of relatively broad entry criteria to accommodate possible changes in diagnosis during followup.
• Comprehensive characterization of the development of the illness should include data on variables such as time and mode of onset of prodromal and psychotic symptoms, decline in social functioning, treatment and hospitalization, and the assessment setting.
• Terms that describe the course of the illness should be defined. These include episode, onset of episode, and end of episode.
• From the perspective of the reviewer, the term first episode should be included as a key word in publications; when studies include both first-and multiple-episode patients, descriptive characterization should be provided separately for the two groups.
The range of studies currently being conducted under the broad umbrella of first-episode psychosis will. before the turn of the century, address and answer many specific questions regarding the etiology and course of schizophrenia. Along the way, we will also learn about the onset of the illness, which symptoms and signs best define it, and their prognostic significance.
